Clinical Trials on West Nile Virus Disease in New Zealand
Total 3489 results
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Alios Biopharma Inc.Completed
-
Gilead SciencesCompleted
-
VaxartCompletedSeasonal Influenza BNew Zealand
-
University of Auckland, New ZealandCompletedVaccinationNew Zealand
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Gilead SciencesCompleted
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Assembly BiosciencesCompleted
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Novartis PharmaceuticalsTerminated
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Gilead SciencesCompleted
-
Antipodean Pharmaceuticals, Inc.Completed
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Valneva Austria GmbHCompleted
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Gilead SciencesCompletedHepatitis B VirusUnited States, Germany, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand